Shareholder Structure
Intercell has a total of 48,592,219 issued shares of common stock, which includes 301,748 shares of treasury stock.
Intercell's major shareholder is Novartis Vaccines & Diagnostics (14.9 percent). 1.9 percent of the shares are held by GSK. Intercell holds 0.6 percent of the shares issued as treasury stock. The current free float is 82.6 percent.